Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples